Longevity Biomedical Deal Approved by Denali Capital Shareholders

Vision Sensing Acquisition, in an 8-K filing, announced a business combination agreement with Mediforum, a biomedical firm exploring Alzheimer’s and memory improvement therapies. The deal’s total consideration is $250 million in stock.

Read more on https://news.spacconference.com/2024/01/17/vision-sensing-acquisition-combining-with-mediforum-in-250m-deal/

Shanda Consult has been working with SPACs for many years, and our network of SPAC executives has deep experience in the sector. If you need to learn more about how to successfully use a SPAC structure and perhaps wish to set up your own SPAC, we are here to help.

Please contact us with any questions you may have.